Am J Kidney Dis
- CURTO A, Pereira TA, Ferreira AC
The Use of Ultrasound in Peritoneal Dialysis Setting.
Am J Kidney Dis. 2024 May 27:S0272-6386(24)00785.
- NIYYAR VD
In Reply to "The Use of Ultrasound in Peritoneal Dialysis Setting".
Am J Kidney Dis. 2024 May 27:S0272-6386(24)00786.
Am J Nephrol
- HORI M, Takahashi H, Kondo C, Hayashi F, et al
Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients
Undergoing Chronic Haemodialysis.
Am J Nephrol. 2024;55:399-405.
Clin Nephrol
- RU Y, Xue L, Zhu MG, Ye X, et al
Sagliker syndrome in a patient with end-stage renal disease and uncontrolled
secondary hyperparathyroidism.
Clin Nephrol. 2024 Jun 5. doi: 10.5414/CN111327.
J Am Soc Nephrol
- PINTER J, Jardine M, Canaud B, Genser B, et al
Authors' Reply: Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis
Initiation by Default?
J Am Soc Nephrol. 2024 Jun 6. doi: 10.1681/ASN.0000000000000376.
- DEGRAAUW J, Wong SPY
Engaging Patients in Decision Making about Treatment of Kidney Failure: The Art
and Science of Communication.
J Am Soc Nephrol. 2024;35:673-675.
J Clin Endocrinol Metab
- HAN WW, Miao MY, Lyu JQ, Tao HW, et al
Female reproductive factors, exogenous hormone use, and incident chronic kidney
disease and end-stage renal disease.
J Clin Endocrinol Metab. 2024 Jun 3:dgae374. doi: 10.1210.
J Nephrol
- YU B, Atta MG, Brennan DC, Kant S, et al
Outcomes and management of kidney transplant recipients with Fabry disease: a
review.
J Nephrol. 2024;37:561-571.
- TARRASS F, Benjelloun M, Piccoli GB
Hemodialysis water reuse within a circular economy approach. What can we add to
current knowledge? A point of view.
J Nephrol. 2024 Jun 3. doi: 10.1007/s40620-024-01989.
- TSENG CH, Hu YA, Chen YT, Yu WC, et al
Beyond prevalence: significance and differential impact of echocardiographic
abnormalities in dialysis patients.
J Nephrol. 2024 Jun 4. doi: 10.1007/s40620-024-01963.
- PRZYGOCKA A, Magnoni G, Picotti M, Rapana R, et al
Rare case of postherpetic abdominal pseudohernia in a patient on peritoneal
dialysis.
J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01954.
- FERNANDEZ LUCAS M, Piris Gonzalez M, Diaz Dominguez ME, Collado Alsina A, et al
Incremental hemodialysis and vascular access complications: a 12-year experience
in a hospital hemodialysis unit.
J Nephrol. 2024 Jun 5. doi: 10.1007/s40620-024-01932.
Kidney Int
- CORKEN AL, Ong V, Kore R, Ghanta SN, et al
Platelets, Inflammation, and Purinergic Receptors in Chronic Kidney Disease.
Kidney Int. 2024 May 29:S0085-2538(24)00381-8. doi: 10.1016/j.kint.2024.
Pediatr Nephrol
- FADEL FI, Salah DM, Mawla MAA, Galal E, et al
Assessment of volume status of pediatric hemodialysis patients.
Pediatr Nephrol. 2024 Jun 6. doi: 10.1007/s00467-024-06409.
PLoS One
- SIM JJ, Shu YH, Bhandari SK, Chen Q, et al
Data driven approach to characterize rapid decline in autosomal dominant
polycystic kidney disease.
PLoS One. 2024;19:e0298484.
Ren Fail
- LIU X, Chen P, Liu Y, Jia X, et al
Medication burden in patients with dialysis-dependent CKD: a systematic review.
Ren Fail. 2024;46:2353341.
- BAI Z, Lu G, Yang H, Zhang D, et al
Seasonal variation of serum potassium in hemodialysis patients: myth or reality?
A narrative review of literature.
Ren Fail. 2024;46:2359640.
- CHEN Z, Zheng Z, Jiang B, Xu Y, et al
Genetic association between celiac disease and chronic kidney disease: a
two-sample Mendelian randomization study.
Ren Fail. 2024;46:2357246.
- LIU W, Weng S, Cao C, Yi Y, et al
Association between monocyte-lymphocyte ratio and all-cause and cardiovascular
mortality in patients with chronic kidney diseases: A data analysis from national
health and nutrition examination survey (NHANES) 2003-2010.
Ren Fail. 2024;46:2352126.
- ZHU M, Bi Z, Wang Y, Li W, et al
Serum hydroxycotinine was associated with chronic kidney disease (CKD): a
cross-sectional study based on NHANES.
Ren Fail. 2024;46:2356024.
Semin Nephrol
- GUHA C, Gallego D, Grandinetti A, Warren M, et al
Patient Perspectives on Clotting in the Extracorporeal Circuit and
Decision-Making Regarding Anticoagulation Therapy.
Semin Nephrol. 2023;43:151475.
Transplantation
- BROOK MO, Hennessy C, Hester J, Hammad S, et al
Late Treatment With Autologous Expanded Regulatory T-cell Therapy After
Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in
Living Donor Renal Transplantation.
Transplantation. 2024 Jun 7. doi: 10.1097/TP.0000000000005065.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016